Sei Investments CO Concert Pharmaceuticals, Inc. Transaction History

Sei Investments CO

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$4.27 - $7.2 $14,202 - $23,947	-3,326 Reduced 3.03%	106,270 $712,000
Q2 2022 Aug 15, 2022	BUY	$2.8 - $6.36 $306,868 - $697,030	109,596 New	109,596 $461,000
Q1 2019 May 15, 2019	SELL	$12.07 - $17.54 $27,350 - $39,745	-2,266 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$11.25 - $16.17 $6,086 - $8,747	541 Added 31.36%	2,266 $24,000
Q3 2018 Nov 08, 2018	SELL	$12.82 - $17.88 $44,254 - $61,721	-3,452 Reduced 66.68%	1,725 $21,000
Q2 2018 Aug 03, 2018	BUY	$16.83 - $21.66 $33,474 - $43,081	1,989 Added 62.39%	5,177 $87,000
Q1 2018 May 11, 2018	BUY	$19.24 - $28.03 $44,848 - $65,337	2,331 Added 272.0%	3,188 $73,000
Q4 2017 Feb 08, 2018	BUY	$13.96 - $29.05 $11,963 - $24,895	857	857 $22,000

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

Stay updated on Sei Investments CO with notifications on news.